{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:16:47Z","timestamp":1790111807424,"version":"4.0.1"},"reference-count":43,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"PPMD"},{"name":"Burroughs Wellcome Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>Duchenne muscular dystrophy (DMD) is a rare neuromuscular disorder diagnosed in childhood. Limited newborn screening in the US often delays diagnosis. With multiple FDA-approved therapies, early diagnosis is crucial for timely treatment but may entail other benefits and harms. Using a community-based survey, we explored how parents of siblings with DMD perceived early diagnosis of one child due to a prior child\u2019s diagnosis. We assessed parents\u2019 viewpoints across domains including diagnostic journey, treatment initiatives, service access, preparedness, parenting, emotional impact, and caregiving experience. We analyzed closed-ended responses on a \u22121.0 to +1.0 scale to measure the degree of harm or benefit parents perceived and analyzed open-ended responses thematically. A total of 45 parents completed the survey, with an average age of 43.5 years and 20.0% identifying as non-white. Younger siblings were diagnosed 2 years earlier on average (p &lt; 0.001). Overall, parents viewed early diagnosis positively (mean: 0.39), particularly regarding school preparedness (+0.79), support services (+0.78), treatment evaluation (+0.68), and avoiding diagnostic odyssey (+0.67). Increased worry was a common downside (\u22120.40). Open-ended responses highlighted improved outlook and health management alongside heightened emotional distress and treatment burdens. These findings address gaps in the evidence by documenting the effectiveness of early screening and diagnosis of DMD using sibling data.<\/jats:p>","DOI":"10.3390\/ijns10020032","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T10:24:26Z","timestamp":1713176666000},"page":"32","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Assessing the Benefits and Harms Associated with Early Diagnosis from the Perspective of Parents with Multiple Children Diagnosed with Duchenne Muscular Dystrophy"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9006-7409","authenticated-orcid":false,"given":"Oindrila","family":"Bhattacharyya","sequence":"first","affiliation":[{"name":"Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7836-5135","authenticated-orcid":false,"given":"Nicola B.","family":"Campoamor","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Foundation for Angelman Syndrome Therapeutics, Austin, TX 78704, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Freed","sequence":"additional","affiliation":[{"name":"Parent Project Muscular Dystrophy, Washington, DC 20005, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Schrader","sequence":"additional","affiliation":[{"name":"Parent Project Muscular Dystrophy, Washington, DC 20005, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah L.","family":"Crossnohere","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH 43202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F. P.","family":"Bridges","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13023-020-01430-8","article-title":"Global epidemiology of Duchenne muscular dystrophy: An updated systematic review and meta-analysis","volume":"15","author":"Crisafulli","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000512647","article-title":"Duchenne and Becker Muscular Dystrophies Prevalence in MD STARnet surveillance sites: An Examination of Racial and Ethnic Differences","volume":"55","author":"Zhang","year":"2021","journal-title":"Neuroepidemiology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ajmg.c.32000","article-title":"Newborn screening for Duchenne muscular dystrophy-early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy","volume":"190","author":"Gruber","year":"2022","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.nmd.2012.06.256","article-title":"31 What was the age and cause of death in patients with Duchenne muscular dystrophy in Sweden during 2000\u20132010?","volume":"22","author":"Stromberg","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100877","DOI":"10.1016\/j.spen.2021.100877","article-title":"Therapeutic Approaches for Duchenne Muscular Dystrophy: Old and New","volume":"37","author":"Mackenzie","year":"2021","journal-title":"Semin. Pediatr. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e2144178","DOI":"10.1001\/jamanetworkopen.2021.44178","article-title":"Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial","volume":"5","author":"Mah","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S1474-4422(22)00125-9","article-title":"Emerging therapies for Duchenne muscular dystrophy","volume":"21","author":"Markati","year":"2022","journal-title":"Lancet Neurol."},{"key":"ref_9","unstructured":"(2024, February 06). Sarepta Therapeutics Announces FDA Approval of ELEVIDYS, the First Gene Therapy to Treat Duchenne Muscular Dystrophy|Sarepta Therapeutics, Inc. Available online: https:\/\/investorrelations.sarepta.com\/news-releases\/news-release-details\/sarepta-therapeutics-announces-fda-approval-elevidys-first-gene."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Mullard, A. (2024). FDA approves on HDAC inhibitor for Duchenne muscular dystrophy. Nat. Rev. Drug Discov.","DOI":"10.1038\/d41573-024-00066-8"},{"key":"ref_11","unstructured":"(2024, February 06). What is the Purpose of Newborn Screening?|NICHD\u2014Eunice Kennedy Shriver National Institute of Child Health and Human Development, Available online: https:\/\/www.nichd.nih.gov\/health\/topics\/newborn\/conditioninfo\/purpose."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/jnnp-2012-303902","article-title":"Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy","volume":"84","author":"Ricotti","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/mus.23304","article-title":"Corticosteroids and duchenne muscular dystrophy: Does earlier treatment really matter?","volume":"45","author":"Mcdonald","year":"2012","journal-title":"Muscle Nerve"},{"key":"ref_15","unstructured":"Dystrophy, P.P.M., and Duchenne Added to New York State\u2019s Newborn Screening Panel (2024, February 19). Parent Project Muscular Dystrophy. Available online: https:\/\/www.parentprojectmd.org\/duchenne-added-to-new-york-states-newborn-screening-panel\/."},{"key":"ref_16","unstructured":"Dystrophy, P.P.M., and Duchenne Added to Minnesota\u2019s Newborn Screening Panel (2024, February 19). Parent Project Muscular Dystrophy. Available online: https:\/\/www.parentprojectmd.org\/duchenne-added-to-minnesotas-newborn-screening-panel\/."},{"key":"ref_17","unstructured":"Dystrophy, P.P.M. (2024, February 19). Duchenne Newborn Screening Milestone\u2014First State with Universal Newborn Screening for Duchenne! Parent Project Muscular Dystrophy. Available online: https:\/\/www.parentprojectmd.org\/duchenne-newborn-screening-milestone-first-state-with-universal-newborn-screening-for-duchenne\/."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/acn3.51829","article-title":"Newborn screening for Duchenne muscular dystrophy: A two-year pilot study","volume":"10","author":"Tavakoli","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101009","DOI":"10.1016\/j.gim.2023.101009","article-title":"Two years of newborn screening for Duchenne muscular dystrophy as a part of the statewide Early Check research program in North Carolina","volume":"26","author":"Kucera","year":"2024","journal-title":"Genet. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Parad, R.B., Sheldon, Y., and Bhattacharjee, A. (2021). Implementation of Hospital-Based Supplemental Duchenne Muscular Dystrophy Newborn Screening (sDMDNBS): A Pathway to Broadening Adoption. Int. J. Neonatal. Screen, 7.","DOI":"10.3390\/ijns7040077"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.nmd.2013.05.008","article-title":"195th ENMC International Workshop: Newborn screening for Duchenne muscular dystrophy 14\u201316th December 2012, Naarden, The Netherlands","volume":"23","author":"Ellis","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mus.27532","article-title":"Time to diagnosis of Duchenne muscular dystrophy remains unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network, 2000\u20132015","volume":"66","author":"Thomas","year":"2022","journal-title":"Muscle Nerve"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jpeds.2018.10.043","article-title":"Evidence-Based Consensus and Systematic Review on Reducing the Time to Diagnosis of Duchenne Muscular Dystrophy","volume":"204","author":"Hegde","year":"2019","journal-title":"J. Pediatr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/mus.23272","article-title":"Early corticosteroid treatment in 4 duchenne muscular dystrophy patients: 14-year follow-up","volume":"45","author":"Merlini","year":"2012","journal-title":"Muscle Nerve"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s10072-018-3555-3","article-title":"Clinical management of Duchenne muscular dystrophy: The state of the art","volume":"39","author":"Messina","year":"2018","journal-title":"Neurol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kharraz, Y., Guerra, J., Pessina, P., Serrano, A.L., and Mu\u00f1oz-C\u00e1noves, P. (2014). Understanding the Process of Fibrosis in Duchenne Muscular Dystrophy. BioMed Res. Int., 2014.","DOI":"10.1155\/2014\/965631"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/ejhg.2014.301","article-title":"A mixed methods study of age at diagnosis and diagnostic odyssey for Duchenne muscular dystrophy","volume":"23","author":"Wong","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/mus.24078","article-title":"Sibling concordance for clinical features of Duchenne and Becker muscular dystrophies","volume":"49","author":"Pettygrove","year":"2014","journal-title":"Muscle Nerve"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Rangel, V., Martin, A.S., and Peay, H.L. (2012). DuchenneConnect Registry Report. PLoS Curr., 4.","DOI":"10.1371\/currents.RRN1309"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ajmg.c.31992","article-title":"Diagnostic experiences of Duchenne families and their preferences for newborn screening: A mixed-methods study","volume":"190","author":"Crossnohere","year":"2022","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ajmg.c.31988","article-title":"Newborn screening for neurodevelopmental diseases: Are we there yet?","volume":"190","author":"Chung","year":"2022","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s10072-020-04307-7","article-title":"Is it the right time for an infant screening for Duchenne muscular dystrophy?","volume":"41","author":"Vita","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/archdischild-2014-306366","article-title":"Improving recognition of Duchenne muscular dystrophy: A retrospective case note review","volume":"99","author":"Straub","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1474-4422(18)30026-7","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 3: Primary care, emergency management, psychosocial care, and transitions of care across the lifespan","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"91F","DOI":"10.1136\/fn.86.2.F91","article-title":"Newborn screening for Duchenne muscular dystrophy: A psychosocial study","volume":"86","author":"Parsons","year":"2002","journal-title":"Arch. Dis. Child.-Fetal Neonatal Ed."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ajmg.c.31993","article-title":"Duchenne expert physician perspectives on Duchenne newborn screening and early Duchenne care","volume":"190","author":"Armstrong","year":"2022","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2214.2005.00518.x","article-title":"Parents\u2019 perspectives on coping with Duchenne muscular dystrophy","volume":"31","author":"Webb","year":"2005","journal-title":"Child Care Health Dev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pedhc.2016.09.002","article-title":"Parental Reflections on the Diagnostic Process for Duchenne Muscular Dystrophy: A Qualitative Study","volume":"31","author":"Bendixen","year":"2017","journal-title":"J. Pediatr. Health Care"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/0883073810389043","article-title":"Quality of Life in Duchenne Muscular Dystrophy: The Subjective Impact on Children and Parents","volume":"26","author":"Baiardini","year":"2011","journal-title":"J. Child Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3109\/09638288.2011.628738","article-title":"Subjective caregiver burden of parents of adults with Duchenne muscular dystrophy","volume":"34","author":"Pangalila","year":"2012","journal-title":"Disabil. Rehabil."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cct.2015.11.006","article-title":"\u201cWatching time tick by\u2026\u201d: Decision making for Duchenne muscular dystrophy trials","volume":"46","author":"Peay","year":"2016","journal-title":"Contemp. Clin. Trials"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-021-01758-9","article-title":"Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?","volume":"16","author":"Kourakis","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1080\/09638288.2022.2060336","article-title":"A systematic review and qualitative synthesis of the experiences of parents of individuals living with Duchenne muscular dystrophy","volume":"45","author":"Donnelly","year":"2023","journal-title":"Disabil. Rehabil."}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/10\/2\/32\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:28:21Z","timestamp":1760106501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/10\/2\/32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["ijns10020032"],"URL":"https:\/\/doi.org\/10.3390\/ijns10020032","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]}}}